INT303600

Context Info Confidence 0.39 First Reported 2010 Last Reported 2010 Negated 1 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 0.83 Pain Relevance 0.14

extracellular space (IGF1, GH1) extracellular region (IGF1, GH1) signal transduction (IGF1)

IGF1 (Homo sapiens) GH1 (Homo sapiens)

Pain Link Frequency Relevance Heat Somatostatin 4 92.72 antagonist 1 80.96 imagery 10 56.88 antidepressant 1 19.44 depression 1 18.08 carpal tunnel syndrome 1 8.40 anesthesia 1 5.00 agonist 1 5.00 Dopamine 1 5.00

Disease Link Frequency Relevance Heat Hypoglycemia 1 88.20 Diabetes Mellitus 3 85.44 Dyspnea 1 84.16 Acromegaly 17 80.08 Hypopituitarism 3 78.08 Pituitary Cancer 6 72.32 Cancer 13 60.00 Cleidocranial Dysplasia 2 50.16 Polyostotic Fibrous Dysplasia 2 41.92 Depression 1 18.08

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

After 11 months of treatment with lanreotide, her IGF-1 and GH levels were largely unchanged from their levels before the treatment (Table 1).

IGF-1 Neg (unchanged) Regulation (unchanged) of Gene_expression (levels) of GH

1) Confidence 0.39 Published 2010 Journal J Med Case Reports Section Body Doc Link PMC2845144 Disease Relevance 0.83 Pain Relevance 0.14

General Comments

This test has worked.